PHESGO

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: 66bd27f283afc2c7
Drug Approval Canada Name: PHESGO
Product Name: PHESGO
Status: Marketed
Status Date: 2021-04-08
Original Market Date: 2021-04-08
Din: 02512912
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FY01 PERTUZUMAB AND TRASTUZUMAB
Atc Name: l 01 fy 01
Aig Number: 0254251002
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

PERTUZUMAB

80 MG / ML

TRASTUZUMAB

40 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

66bd27f283afc2c7

Type

Standard